Skip to main content
. 2021 Feb 8;31(5):670–678. doi: 10.1136/ijgc-2020-002120

Table 2.

Primary outcomes

Outcome LDR HDR P value
Local control at 2 years
 IB 63% 61% 0.35
 IIA 86% 90% 0.68
 IIB 86% 88% 0.83
 IIIA 66% 60% 0.56
 IIIB 77% 40% 0.005
Disease-free survival at 2 years
 IB 64% 61% 0.50
 IIA 81% 69% 0.18
 IIB 81% 80% 0.54
 IIIA 62% 33% 0.82
 IIIB 71% 30% 0.001
Overall survival at 2 years
 IB 94% 93% 0.92
 IIA 98% 68% 0.21
 IIB 89% 88% 0.60
 IIIB 88% 82% 0.34

HDR, high-dose rate brachytherapy; LDR, low-dose rate brachytherapy.